InsidersTradesSigma
Total declarations
Companies
▲ Purchases (17 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
17
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by MIDDLETON FRED A, Director. Officer active across 4 companies, notably CHIMERIX INC. In total, 20 disclosures have been recorded. Breakdown: 17 buys · 0 sell. Total volume traded: €1.1m. Activity tracked since 25 June 2021. The latest transaction was disclosed on 21 April 2025 (Disposition). Regulator: SEC (Form 4). All data is openly available.
Declarations20 total
248,972 sharesCommon StockSEC:0001267959-26-000003:0
Ideal exit: 22 Mar 2027 (T+270)
40,000 shares@ US$8.5563.0% of flowCommon StockSEC:0001415889-25-011076:0
4,800 shares@ US$2.651.3% of flowCommon StockSEC:0001415889-24-028563:0
Ideal exit: 2 Sept 2025 (T+270)
20,000 shares@ US$3.757.3% of flowCommon StockSEC:0001415889-24-026102:0
Ideal exit: 29 Jul 2025 (T+270)
60,000 shares0Common StockSEC:0001415889-24-025802:0
243,356 shares@ US$3.70288.0% of flowCommon StockSEC:0001415889-24-001831:0
Ideal exit: 19 Oct 2024 (T+270)
17,295 shares@ US$0.95533.2% of flowCommon StockSEC:0001209191-23-056008:0
Ideal exit: 13 Aug 2024 (T+270)
2,705 shares@ US$0.920.5% of flowCommon StockSEC:0001209191-23-055026:0
Ideal exit: 6 Aug 2024 (T+270)
20,000 shares@ US$0.981811.8% of flowCommon StockSEC:0001209191-23-050548:0
Ideal exit: 21 Jun 2024 (T+270)
714 shares@ US$5.200.4% of flowCommon StockSEC:0001209191-23-036129:0
Ideal exit: 5 Mar 2024 (T+270)
500 shares@ US$4.88080.2% of flowCommon StockSEC:0001209191-23-035613:0
Ideal exit: 2 Mar 2024 (T+270)
10,000 shares@ US$2.852.8% of flowCommon StockSEC:0001209191-23-031382:0
Ideal exit: 13 Feb 2024 (T+270)
20,000 shares@ US$1.20764.7% of flowCommon StockSEC:0001209191-23-021480:0
Ideal exit: 23 Dec 2023 (T+270)
703,388 sharesCommon StockSEC:0001209191-23-020684:0
20,000 shares@ US$1.85888.0% of flowCommon StockSEC:0001209191-22-051733:0
Ideal exit: 26 Jun 2023 (T+270)
20,000 shares@ US$2.036949.2% of flowCommon StockSEC:0001209191-22-030943:0
Ideal exit: 13 Feb 2023 (T+270)
3,050 shares@ US$7.784.2% of flowCommon StockSEC:0001209191-21-043709
Ideal exit: 22 Mar 2022 (T+270)
3,050 shares@ US$7.7825.4% of flowCommon StockSEC:0001209191-21-043709:0
Ideal exit: 22 Mar 2022 (T+270)
20,000 sharesCommon StockSEC:0001144204-16-076291:0
Ideal exit: 11 Oct 2016 (T+270)
10,000 sharesCommon StockSEC:0001144204-16-076291:1
Ideal exit: 15 Oct 2016 (T+270)
20 of 20 declarations
About MIDDLETON FRED A
Middleton Fred A. is a Board Member at Chimerix Inc. In this role, he participates in the governance of the company and the development of its strategy. His expertise in the pharmaceutical field allows him to make significant contributions to board discussions. He is committed to supporting Chimerix's mission and fostering its growth.
